A Clinical Study of T3011 in Subjects With Advanced Melanoma

A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma

NCT03422445 ·Status: UNKNOWN ·Phase: PHASE2

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

NCT01308762 ·Status: COMPLETED ·Phase: PHASE1

Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

NCT04248387 ·Status: UNKNOWN ·Phase: PHASE2

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

NCT05827770 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)

NCT02821000 ·Status: COMPLETED ·Phase: PHASE1

A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma

NCT06727630 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma

NCT02211131 ·Status: COMPLETED ·Phase: PHASE2

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma

NCT07280832 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

NCT03273153 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

NCT04653038 ·Status: TERMINATED ·Phase: PHASE1

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

NCT04666272 ·Status: ACTIVE_NOT_RECRUITING

Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study

NCT04462965 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma

NCT05478473 ·Status: UNKNOWN ·Phase: NA

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

NCT05106023 ·Status: UNKNOWN ·Phase: PHASE2

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

NCT00057616 ·Status: COMPLETED ·Phase: PHASE3

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

NCT04072900 ·Status: UNKNOWN ·Phase: PHASE1

CP-461 in the Treatment of Patients With Advanced Melanoma

NCT00060710 ·Status: TERMINATED ·Phase: PHASE2

Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma

NCT02141542 ·Status: COMPLETED ·Phase: PHASE1

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

NCT00027742 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)

NCT05116202 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

NCT04884997 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma

NCT02723006 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma

NCT02110355 ·Status: COMPLETED ·Phase: PHASE1

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

NCT02965716 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

NCT01709162 ·Status: TERMINATED ·Phase: PHASE2